Two Sigma Securities’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,119
| Closed | -$51.4K | – | 1544 |
|
|
2024
Q1 | $51.4K | Buy |
+10,119
| New | +$51.4K | ﹤0.01% | 1072 |
|
|
2023
Q2 | – | Sell |
-25,030
| Closed | -$209K | – | 1277 |
|
|
2023
Q1 | $209K | Buy |
+25,030
| New | +$209K | ﹤0.01% | 806 |
|
|
2021
Q1 | – | Sell |
-10,194
| Closed | -$76K | – | 618 |
|
|
2020
Q4 | $76K | Buy |
+10,194
| New | +$76K | ﹤0.01% | 553 |
|
|
2020
Q2 | – | Sell |
-20,058
| Closed | -$40K | – | 595 |
|
|
2020
Q1 | $40K | Buy |
+20,058
| New | +$40K | ﹤0.01% | 518 |
|
|
2017
Q2 | – | Sell |
-10,396
| Closed | -$87K | – | 865 |
|
|
2017
Q1 | $87K | Buy |
+10,396
| New | +$87K | 0.02% | 765 |
|